GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

ANG-PD · Sep 30, 2024

American National Group Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001039828-24-000079Insurance
Cash95thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.cash

$13.9B · CORE · VALID

DebtRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.gross_debt

$3.0B · OPTIONAL · NOT_ENOUGH_HISTORY

Net-income growth5thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.net_income

-160.48% · CORE · VALID

Premium growth95thOwn-history percentile · N=20
Evidence method

Yoy · gp.insurance.premiums

33321.15% · CORE · VALID

Revenue growth100thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.revenue

651.54% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History51 statesSelf-history eligible
Period transition

What moved in the state?

Cash Decreased
Previous
$13.9B
Current
$13.9B
Delta
-$22.0M
Debt Increased
Previous
$2.5B
Current
$3.0B
Delta
$483.0M
Earnings Growth Decreased
Previous
-31.34%
Current
-160.48%
Delta
-129.15%
Premium Growth Decreased
Previous
39844.36%
Current
33321.15%
Delta
-6523.20%
Revenue Growth Increased
Previous
148.34%
Current
651.54%
Delta
503.20%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.